Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
      QxMD      Google Scholar   
Citation:
Leukemia vol 29 (3) 567-575
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
4
Parents:
977  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, P50 CA140158, U10 CA180861, CA140158, CA16058, CA101140, U10 CA077658, U10 CA031946, R21 CA129657, U10 CA033601, U10 CA180821, U24 CA114725, U10 CA180850, U10 CA101140, U10 CA180882, P30 CA016058, CA77658, T32 GM068412, CA129657, CA114725, CA31946  
Corr. Author:
Christian Niederwieser 
Authors:
                                                       
Networks:
CA043, IA018, LAPS-AL002, LAPS-IL057, LAPS-MA036, LAPS-MD017, LAPS-NC010, LAPS-OH007, MD015, NC002, NORTHWELL   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8461, CALGB-9665, CALGB-10201, CALGB-20202, CALGB-8525, CALGB-8923, CALGB-9420, CALGB-9720
Phases:
1, 3, N/A
Keywords:
acute myeloid leukemia, DNMT3B expression, prognostication, gene-expression profiling